CELIA
OREJA GUEVARA
Profesora asociada de Ciencias de la Salud
Instituto de Investigación Sanitaria del Hospital Clínico San Carlos
Madrid, EspañaInstituto de Investigación Sanitaria del Hospital Clínico San Carlos-ko ikertzaileekin lankidetzan egindako argitalpenak (6)
2022
-
Eculizumab monotherapy for NMOSD: Data from PREVENT and its open-label extension
Multiple Sclerosis Journal, Vol. 28, Núm. 3, pp. 480-486
2021
-
A plea for equitable global access to COVID-19 diagnostics, vaccination and therapy: The NeuroCOVID-19 Task Force of the European Academy of Neurology
European Journal of Neurology, Vol. 28, Núm. 11, pp. 3849-3855
-
EAN consensus statement for management of patients with neurological diseases during the COVID-19 pandemic
European Journal of Neurology, Vol. 28, Núm. 1, pp. 7-14
-
Natalizumab, Fingolimod, and Dimethyl Fumarate Use and Pregnancy-Related Relapse and Disability in Women With Multiple Sclerosis
Neurology, Vol. 96, Núm. 24, pp. E2989-E3002
-
Primary prevention of COVID-19: Advocacy for vaccination from a neurological perspective
European Journal of Neurology
2020
-
The international European Academy of Neurology survey on neurological symptoms in patients with COVID-19 infection
European Journal of Neurology, Vol. 27, Núm. 9, pp. 1727-1737